Increased dose-intensity in small-cell lung cancer: A failed strategy?

被引：9
|
作者：
Johnson, DH [1 ]
Carbone, DP [1 ]
机构：
[1] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Med,Div Hematol & Oncol, Nashville, TN 37212 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1999年 / 17卷 / 08期
关键词：
D O I：
10.1200/JCO.1999.17.8.2297
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2297 / 2299
页数：3
相关论文
共 50 条
  • [21] Increased Expression and Activation of FAK in Small-Cell Lung Cancer Compared to Non-Small-Cell Lung Cancer
    Nana, Frank Aboubakar
    Hoton, Delphine
    Ambroise, Jerome
    Lecocq, Marylene
    Vanderputten, Marie
    Sibille, Yves
    Vanaudenaerde, Bart
    Pilette, Charles
    Bouzin, Caroline
    Ocak, Sebahat
    [J]. CANCERS, 2019, 11 (10)
  • [22] HIGH-DOSE IFOSFAMIDE IN SMALL-CELL LUNG-CANCER
    WARENIUS, HM
    HURMAN, DC
    COTTIER, B
    [J]. BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 216 - 216
  • [23] HIGH-DOSE CYTARABINE IN SMALL-CELL LUNG-CANCER
    OSBORNE, RJ
    CLARK, PI
    SLEVIN, ML
    WRIGLEY, PFM
    [J]. CANCER TREATMENT REPORTS, 1987, 71 (04): : 417 - 418
  • [24] DOSE-INTENSIVE THERAPY FOR SMALL-CELL LUNG-CANCER
    ELIAS, AD
    [J]. CHEST, 1995, 107 (06) : S261 - S266
  • [25] THE IMPACT OF DOSE INTENSITY OF STANDARD CHEMOTHERAPY REGIMENS IN EXTENSIVE-STAGE SMALL-CELL LUNG-CANCER
    SHEEHAN, RG
    BALABAN, EP
    FRENKEL, EP
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (03): : 250 - 255
  • [26] A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: Summation dose-intensity
    Hryniuk, W
    Frei, E
    Wright, FA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (09) : 3137 - 3147
  • [27] Ipilimumab in non-small cell lung cancer and small-cell lung cancer: new knowledge on a new therapeutic strategy
    Rijavec, Erika
    Genova, Carlo
    Barletta, Giulia
    Burrafato, Giovanni
    Biello, Federica
    Dal Bello, Maria Giovanna
    Coco, Simona
    Truini, Anna
    Alama, Angela
    Boccardo, Francesco
    Grossi, Francesco
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (07) : 1007 - 1017
  • [28] Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO)
    Tibaldi, C
    Ricci, S
    Russo, F
    Bernardini, I
    Galli, L
    Chioni, A
    Orlandini, C
    Grosso, AM
    Pegna, AL
    Fabbri, A
    Innocenti, F
    Ferrari, K
    Tognarini, L
    Conte, PF
    Falcone, A
    [J]. LUNG CANCER, 2005, 48 (01) : 121 - 127
  • [29] Treatment for small-cell lung cancer
    Saadeen, Ahmed
    Jazieh, Abdul-Rahman
    [J]. ANNALS OF THORACIC MEDICINE, 2008, 3 (06) : S100 - S103
  • [30] Pathology of small-cell lung cancer
    Junker, K
    Wiethege, T
    Müller, KM
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (07) : 361 - 368
12345